Two wafer fab capacity allocations secured. Six new pluggable customers qualified. ASP trending upward across the entire product line. Supply bottlenecks reported across the optical module chain. And yet โ an activist investor is publicly challenging Sivers Photonics' strategic direction. That's a state root mismatch. The operating data says one thing; the market narrative says another.
Serenity's letter isn't about technology. It's about storytelling โ specifically, who tells the story, and to which audience. The activist's core argument: Sivers is wasting its growth narrative on Swedish domestic investors focused on short-term cash burn, while American institutional capital โ which pays premium multiples for AI supply chain exposure โ remains untapped. The prescription: pivot the investor communications strategy westward.
From where I sit, having spent years auditing Layer2 infrastructure and, more recently, tracing supply chain constraints across AI-driven optical interconnects, that framing is incomplete. The real question isn't whether Sivers should court American investors. It's whether the company can execute fast enough to match its own expanding capacity โ before the competitive window closes.
Sivers Photonics is a UK-based III-V compound semiconductor IDM headquartered in London. It designs and manufactures photonic chips on GaAs and InP substrates โ DFB lasers, EMLs (electro-absorption modulated lasers), and components for silicon photonics integration. Process nodes sit in the 250-500nm range, which sounds primitive by logic-chip standards. That's irrelevant here. Photonic chips don't follow Moore's Law; they follow yield curves, coupling efficiency, and thermal stability. The company operates in the optical communication supply chain's highest-value segment โ laser chips account for 30-50% of an optical module's BOM cost, and leading players sustain 50-60% gross margins.
The AI buildout has fundamentally reshaped this market. 800G modules are scaling; 1.6T is entering production. A single AI training server now consumes 32-64 optical modules versus 8-16 just two years ago. Industry forecasts put optical module demand growth at 25-35% CAGR through 2028-2030. That demand shock created a genuine seller's market. And Sivers โ with differentiated DFB laser expertise at specific wavelengths โ sits in the middle of it.
Let me break down what the company's disclosures and the activist letter actually tell us.
First, the two wafer fab capacity allocations. The company hasn't disclosed investment amounts. That's telling. A small-cap IDM securing external foundry capacity โ likely through partnerships with Asian foundries like Win Semiconductors or similar โ rather than building its own fabs, is a capital-light strategy. The capex-to-revenue ratio for a company this size typically runs 20-30%; external partnerships preserve cash while expanding capacity. But this introduces yield-transfer risk. Moving a laser diode process between fabs isn't trivial. III-V photonic chip yields run 60-85% depending on device type, and process transfers initially compress that range. The ramp timeline โ from equipment move-in to volume production โ typically spans 6-12 months for compound semiconductors. That puts meaningful revenue contribution in 2026.
Second, the six new pluggable customers. This is the core of the near-term growth story. In the 800G/1.6T pluggable module market, customer qualification cycles run 12-18 months. Six new customers passing qualification simultaneously suggests Sivers' design wins are compounding. Customer concentration risk is real โ top-five customers likely account for 60-80% of revenue โ but a broadening base is precisely how you de-risk that concentration. The hidden signal: these are likely module makers supplying US hyperscalers, which aligns with Serenity's US-market thesis.
Third, the CPO and ELS positioning. This is the long-term story. CPO โ co-packaged optics โ places optical engines directly adjacent to switching ASICs, cutting power consumption and latency. The external laser source (ELS) is a critical component in the silicon photonics CPO route. Sivers' partnership with O-Net on ELS products, plus potential supply relationships with CPO pioneers like Ayar Labs (Intel-backed, with expansion plans through 2028), positions the company at the upstream core of this supply chain. The CPO market is projected to reach $50-100 billion by 2028. Even a 5-10% share represents a 5-10x revenue upside from Sivers' current base.
Fourth, the supply-demand dynamics. Serenity explicitly cites ASP increases and supply bottlenecks. This aligns with my independent assessment: InP substrate capacity is tight globally; MOCVD equipment lead times run 6-12 months; the entire chain operates at 90%+ utilization. This is a genuine seller's market. Sivers' pricing power is improving, which should push gross margins from the current 35-45% range toward 40-50% as high-speed product mix improves. The company's technology gap with Lumentum and Coherent is roughly 1-2 product generations โ about 2-4 years โ but in CPO and ELS, the gap narrows to 1-1.5 years. This is a narrowing gap, not a static one.
Geopolitically, Sivers operates in a relatively shielded position. Photonic chips aren't on any US export control list. MOCVD equipment is available from Veeco, AIXTRON, and increasingly AMEC in China. InP substrates come primarily from Sumitomo Electric and JX Metals โ Japanese suppliers not subject to US restrictions. The technology decoupling risk is low, rated roughly 3 out of 10. Sivers, as a UK company, can serve both US and Chinese markets without the export license friction that plagues logic chip suppliers. That's a structural advantage Serenity's letter underweights.
But here's the financial tension. Sivers' ROIC likely sits at 2-5% against a WACC of 10-12%. That's value destruction at current capital levels. The valuation โ 8-15x price-to-sales, 30-50x EV/EBITDA โ prices in significant growth. Serenity's argument that the company's investor communications are misfocused on Swedish domestic markets isn't wrong from a capital markets perspective. US AI infrastructure spend is the single largest demand pool for optical components, and US investors have demonstrated willingness to pay premium multiples for AI optical supply chain exposure.
Now the contrarian angle. The real blind spot isn't the market narrative โ it's execution. Two capacity allocations, six new customers, and a CPO roadmap look strong in a shareholder letter. But III-V photonics doesn't scale like digital logic. Yield learning curves are slower. Device reliability for CPO applications โ where a single laser failure can take down an entire switch fabric โ demands qualification standards that take multiple cycles to satisfy. The 12-18 month qualification window means revenue from those six new customers won't fully materialize until late 2026 at best.
And there's a longer-term substitution risk. Silicon photonics โ integrating photonic functions directly into silicon โ could partially displace traditional III-V laser solutions. Sivers hedges through ELS products, which ironically increases III-V content in silicon photonic systems. But the hedge only works if ELS becomes the dominant CPO light source architecture. If integrated solutions win instead, Sivers' core product line faces structural demand erosion.
Chinese competitors โ Yuanjie Technology, Yunling Optoelectronics โ are closing the gap in DFB/EML lasers, still behind at 800G+ speeds but advancing quickly. The competitive window is 2026-2028. If Sivers executes on capacity and customer expansion, it widens the moat. If it stumbles on yield or delivery, the valuation compresses 30-50%, and the activist narrative becomes self-fulfilling.
There's also the potential that Serenity's intervention triggers strategic outcomes beyond communication shifts โ management changes, asset restructuring, or even acquisition interest from larger players like Lumentum or Coherent. At current valuations, a 50-100% acquisition premium isn't unreasonable for a competitor seeking CPO-ready laser capacity.
The Sivers-Serenity dispute is really a disagreement about time horizons. Serenity sees a marketing problem; the deeper truth is an execution problem. The technology is right. The market timing is right. The capacity is being secured. What remains unproven: whether a small-cap IDM can convert third-party fab capacity into reliable, high-yield laser chips at the pace the market expects. Opcode leaked. Liquidity drained โ or not. By 2026, we'll have our answer. State root mismatch. Trust updated.


